Condition
Gastroesophageal Varices Hemorrhage
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
4 shownOptimizing Endoscopic and Interventional Treatment for Portal Hypertensive BleedingNCT07502729 · 2026-03-17
NOT_YET_RECRUITINGManagement of Oxaliplatin-related Gastroesophageal Variceal BleedingNCT05141617 · 2021-11-03
UNKNOWNOxaliplatin-induced Portal HypertensionNCT04524676 · 2020-08-31
UNKNOWNA Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)NCT01451658 · 2009-12-01
UNKNOWNCommon interventions
Leading sponsors
Trial status mix
UNKNOWN3
NOT_YET_RECRUITING1
Phase mix
NA2
PHASE41
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.